unknown
Stage
About
AllInBio is developing a precision immunology approach to identify genetically predisposed "at-risk" patient populations for chronic inflammatory diseases and enable their selection and early treatment to prevent rapid progression to severe disease.
Explore AllInBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.